Omslagsbild

Towards the elimination of viral hepatitis in Thailand by the year 2030

Viral hepatitis is a global problem with mortality comparable to HIV, tuberculosis and malaria. The WHO aims to eliminate hepatitis B (HBV) and hepatitis C (HCV) by 2030. Improved socioeconomic status of developing countries such as Thailand has reduced the incidence and morbidity associated with he...

Full beskrivning

Sparad:

Bibliografiska uppgifter
Huvudupphovsmän:	Nawarat Posuwan (Författare, medförfattare), Nasamon Wanlapakorn (Författare, medförfattare), Palittiya Sintusek (Författare, medförfattare), Rujipat Wasitthankasem (Författare, medförfattare), Kittiyod Poovorawan (Författare, medförfattare), Sompong Vongpunsawad (Författare, medförfattare), Yong Poovorawan (Författare, medförfattare)
Materialtyp:	Bok
Publicerad:	Elsevier, 2020-09-01T00:00:00Z.
Ämnen:	article
Länkar:	Connect to this object online.
Taggar:	Lägg till en tagg Inga taggar, Lägg till första taggen!

Liknande verk

Seroprevalence of an antibody against diphtheria, tetanus, and pertussis among the elderly in Khon Kaen, Thailand
av: Teeraporn Chinchai, et al.
Publicerad: (2019)

Seroprevalence of antibodies against varicella zoster virus across all age groups during the post-COVID-19 pandemic period in Chonburi Province, Thailand
av: Thanunrat Thongmee, et al.
Publicerad: (2024)

Antibody persistence to diphtheria toxoid, tetanus toxoid, Bordetella pertussis antigens, and Haemophilus influenzae type b following primary and first booster with pentavalent versus hexavalent vaccines
av: Nasamon Wanlapakorn, et al.
Publicerad: (2024)

The global campaign to eliminate HBV and HCV infection: International Viral Hepatitis Elimination Meeting and core indicators for development towards the 2030 elimination goals
av: Stephanie Popping, et al.
Publicerad: (2019)

Durability of immune response against omicron BA.2 and BA.4/5 and T cell responses after boosting with mRNA and adenoviral vector-based vaccines following heterologous CoronaVac/ChAdOx-1nCov-19 vaccination
av: Nungruthai Suntronwong, et al.
Publicerad: (2023)

Viral Hepatitis - marching toward the elimination
av: Thilanga Ruwanpathirana
Publicerad: (2023)

Envisaging political commitment and financial investment to accomplish elimination of all forms of viral hepatitis by 2030
av: Saurabh RamBihariLal Shrivastava, et al.
Publicerad: (2020)

Health care burden and mortality of acute on chronic liver failure in Thailand: a nationwide population-based cohort study
av: Sakkarin Chirapongsathorn, et al.
Publicerad: (2022)

Hepatitis C elimination by 2030 in Malaysia: an achievable goal?
av: Rosmawati Mohamed, et al.
Publicerad: (2019)

One Life, One Liver - Toward the elimination of viral hepatitis
av: Dilini Mataraarachchi
Publicerad: (2023)

P23 Strategies towards the elimination of viral hepatitis in Queensland
av: K. Haynes, et al.
Publicerad: (2017)

Report from the International Viral Hepatitis Elimination Meeting (IVHEM), 17-18 November 2017, Amsterdam, the Netherlands: gaps and challenges in the WHO 2030 hepatitis C elimination framework
av: Ste.phanie Popping, et al.
Publicerad: (2018)

Time for India to move towards rabies elimination by 2030!
av: Gyanendra Gongal
Publicerad: (2019)

Art and viral hepatitis elimination programmes
av: Maryam Nima, et al.
Publicerad: (2018)

Effectiveness of HPV vaccine as part of national immunization program for preventing HPV infection in Thai schoolgirls after seven years post-vaccination
av: Pornjarim Nilyanimit, et al.
Publicerad: (2024)

Behavioral prevention of HBV transmission in urban communities toward global elimination of hepatitis in 2030: a systematic review
av: Fiya Diniarti, et al.
Publicerad: (2024)

Possible Strategies for the Implementation of who Program on the Elimination of Hepatitis C in Ukraine by 2030
av: I. Zaytsev, et al.
Publicerad: (2018)

The role of the Primary Healthcare Network in Iran in hepatitis C virus elimination by 2030
av: Masoud Behzadifar, et al.
Publicerad: (2018)

Possible Strategies for the Implementation of who Program on the Elimination of Hepatitis C in Ukraine by 2030
av: I. Zaytsev, et al.
Publicerad: (2018)

Elimination of viral hepatitis: Evolution and India's response
av: Dandu Chandra Sekhar Reddy
Publicerad: (2019)

Safety and immunogenicity of heterologous and homologous inactivated and adenoviral-vectored COVID-19 vaccine regimens in healthy adults: a prospective cohort study
av: Nasamon Wanlapakorn, et al.
Publicerad: (2022)

Viral Hepatitis Elimination Strategies and Impact of COVID-19
av: Aniqa Abdul Rasool, et al.
Publicerad: (2024)

Sustainable development of leprosy elimination by 2030 in China
av: Jue Liu
Publicerad: (2024)

Barriers to eliminating HIV transmission in England by 2030
av: Brooke E Nichols, et al.
Publicerad: (2021)

Pivoting to protein: the immunogenicity and safety of protein-based NVX-CoV2373 as a heterologous booster for inactivated and viral vector COVID-19 vaccines
av: Anthony M. Marchese, et al.
Publicerad: (2023)

Towards the elimination and eradication of hepatitis B
av: Geoffrey Dusheiko
Publicerad: (2015)

Eliminating morbidity caused by neglected tropical diseases by 2030
av: Theresa Gyorkos, et al.
Publicerad: (2023)

2030 - Countdown to malaria elimination in India and southeast Asia
av: The Lancet Regional Health - Southeast Asia
Publicerad: (2022)

The civil society monitoring of hepatitis C response related to the WHO 2030 elimination goals in 35 European countries
av: M. Maticic, et al.
Publicerad: (2020)

The elimination of human African trypanosomiasis: Monitoring progress towards the 2021-2030 WHO road map targets.
av: Jose R Franco, et al.
Publicerad: (2024)

The challenges of viral hepatitis elimination: a global response to a global problem
av: Antony P. Black, et al.
Publicerad: (2023)

Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia
av: Fassil Shiferaw, et al.
Publicerad: (2016)

Rabies Elimination by 2030: What Challenges Does Iran Face?
av: Hamed EBRAHIMZADEH LEYLABADLO, et al.
Publicerad: (2020)

How far are we? Assessing progress in hepatitis C response towards the WHO 2030 elimination goals by the civil society monitoring in 25 European countries, period 2020 to 2023
av: Mojca Maticic, et al.
Publicerad: (2024)

Correction: The challenges of viral hepatitis elimination: a global response to a global problem
av: Antony P. Black, et al.
Publicerad: (2023)

The Key Role of Non-governmental Organizations (NGOs) Activities in Viral Hepatitis Elimination Programs
av: Farzaneh Padami, et al.
Publicerad: (2019)

Erratum to: Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia
av: Fassil Shiferaw, et al.
Publicerad: (2016)

Modelling population dynamics and seasonal movement to assess and predict the burden of melioidosis.
av: Wiriya Mahikul, et al.
Publicerad: (2019)

Viral hepatitis and HIV-associated tuberculosis: Risk factors and TB treatment outcomes in Thailand
av: Likanonsakul Sirirat, et al.
Publicerad: (2008)

Cuba. Escenarios demográficos hacia 2030 Cuba. Demographic scenarios towards 2030
av: Juan Carlos Albizu-Campos Espiñeira
Publicerad: (2015)